Vascular injury is cured with emergent control of the vascular injury. Obtaining both proximal and distal control of the injured vessel with direct pressure is crucial in vascular injury treatment. Mapping of the blood vessels of all injured limbs is vital in treatment. An emergent conversion to an open incision is usually required if a serious vascular injury has occurred. Vascular injury shows symptoms depend on the swelling, location of the injury, pain and bleeding, these are some common symptoms. Also numbness and weakness round the injury are some additional symptoms.Vascular Injury Treatment Market was valued at USD 2.81 Billion in 2019 and is projected to succeed in USD 4.43 Billion by 2028, growing at a CAGR of 6.9% from 2019 to 2028.

Top Driver: Constant technological advances across the world drive the market growth

The major factors supporting the market growth are increasing vascular injuries and consistent technological advances across the world . Also, introduction of novel treatment options for vascular injuries would further boost the market growth. On the opposite hand delayed identification and negligence towards treatment are a number of the factors which may impede the market growth. Increasing vascular injuries are creating demand for vascular injury treatment market across the world . Because the increase in road accidents, violence, cuts there’s increase in occurrence of trauma of vascular injury, so it creates the potential for vascular injury treatment market. Government funding in research activities and therefore the healthcare sector is increased and has helped in market growth. However high cost of treatment might hamper the expansion of marketplace for vascular injury treatment market during the forecasted period.

Bypass graft to Make Crucial Contribution for Growth of Global Vascular injury Market

The global vascular injury treatment market is segmented by treatment type into bypass graft, patch angioplasty, extra-anatomic bypass, lateral arteriorrhaphy/ venorrhaphy, thrombectomy, and others. Among these, the bypass graft segment is dominating the vascular injury treatment market in 2019, owing to rising incidence rates and increasing health complications associated with several vascular diseases. Some of the severe vascular disorders such as peripheral artery disease (PAD), stroke, carotid artery disease (CAD), arteriovenous malformation (AVM), pulmonary embolism, abdominal aortic aneurysm (AAA), deep vein thrombosis (DVT), critical limb ischemia (CLI), chronic venous insufficiency (CVI), and varicose veins are increasing the demand for the treatment of these disorders. 

The National Institutes of Health (NIH), around 14 million men and women are affected by coronary heart disease in the United States. It is one of the most disorder in the elderly population over 65 years old. It is caused by a waxy substance called a plaque which accumulates blood to the heart muscle in the arteries. In this, the bypass graft is the most common treatment for vascular injury to improve the poor flow of blood to the heart. This treatment reduces the risk of severe complications for individuals with obstructive coronary artery disease, a form of heart disease ischemic. Hence, the demand for bypass graft is increasing and is expected to drive the growth off market over the forecast period.

North America Dominates the Market and Expected to try to same within the Forecast Period

North America is predicted to take care of its supremacy within the overall vascular injury treatment market, throughout the forecast period. The increasing prevalence of vascular diseases is that the major factor expected to drive the general growth of the market, during the forecast period. Furthermore, there’s an increase in geriatric population within the us, which is predicted to make more opportunities for the peripheral vascular treatment market within the region.

Asia Pacific is expected to exhibit highest CAGR over the forecast period. This is attributed to increase in the occurrence of trauma due to the increase in the road traffic is the factor that are expected to drive growth of the global vascular injury treatment market in the region. For instance, according to the WHO, over 90% road traffic death occur in low and middle income countries.

Players to Focus on Vascular injury Market

The leading companies in the Global Vascular Injury Treatment market are

• Cleveland Clinic,
• Apollo Hospitals Enterprise Ltd.
• Massachusetts General Hospital
• Heidelberg University Hospital
• Royal Berkshire NHS Foundation Trust
• Universal Health Services, Inc.
• Tenet Healthcare
• Mayo Clinic Health System
• Mediclinic International
• IHH Healthcare Berhad

Mayo Clinic; In April 2019, Mayo Clinic has collaborated with the Children’s Hospital Colorado to find a solution for hypoplastic left heart syndrome.

Universal Health Services: In 2018, the Universal Health Services has acquired the Danshell Group, which includes 25 behavioral health facilities in the U.K. Also, the company has acquired a 109-bed behavioral healthcare facility located in Gulfport, Mississippi.

Eko ; In October 2018, Eko collaborated with Mayo Clinic to develop data-driven technology which helps detect heart diseases.

Scope of the Report

By Treatment

• Lateral Arteriorrhaphy/ Venorrhaphy
• Patch Angioplasty
• Bypass Graft

By injury type

• Spasm
• Thrombosis
• Arteriovenous (AV) Fistula
• Contusion/Intimal Flap

By End User

• Ambulatory Surgical Centers
• Hospitals
• Clinics

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report 

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.